Expression of HLA G in human tumors is not a frequent event

International Journal of Cancer

Volumn 81, Issue 4, 1999, Pages 512-518

  Real, Luis Miguel ^a   Cabrera, Teresa ^a   Collado, Antonia ^a   Jimenez, Pilar ^a   Garcia, Angel ^a   Ruiz Cabello, Francisco ^a   Garrido, Federico ^a  

^a HOSPITAL UNIVERSITARIO VIRGEN DE LAS NIEVES   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

HLA G ANTIGEN;

ANTIGEN EXPRESSION; ARTICLE; CANCER CELL CULTURE; CANCER IMMUNOLOGY; HLA SYSTEM; HUMAN; HUMAN CELL; HUMAN TISSUE; MALIGNANT NEOPLASTIC DISEASE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ANALYSIS; SOLID TUMOR;

ANTIBODIES, MONOCLONAL; COLONIC NEOPLASMS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HISTOCOMPATIBILITY ANTIGENS CLASS I; HLA ANTIGENS; HLA-A ANTIGENS; HLA-B ANTIGENS; HLA-C ANTIGENS; HUMANS; LARYNGEAL NEOPLASMS; NEOPLASMS; PANCREATIC NEOPLASMS; PLACENTA; PREGNANCY; TUMOR CELLS, CULTURED;

EID: 0032927788     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19990517)81:4<512::AID-IJC2>3.0.CO;2-O     Document Type: Article

References (33)

1. ABRIL, E., MENDEZ, R.E., GARCÍA, A., SERRANO, A., CABRERA, T., GARRIDO, F. and RUIZ-CABELLO, F., Characterization of a gastric tumor cell line defective in MHC class I inducibility by both α-and γ-interferon. Tissue Antigens, 47, 391-398 (1996).
2. AMIOT, L., ONNO, M., DRENOU, B., LAMY, T. and FAUCHET, R., Expression of HLA G in malignant hematopoietic cell. First International Conference on HLA-G, July 6-7, Paris, France (1998).
3. BARNSTABLE, C.J., BOOMER, W.F., BROWN, G., GALFRE, B.B., MILSTEIN, C., WILLIAMS, A.F. and ZIEGLER, A., Production of monoclonal antibodies to group A erythrocytes HLA and other human cell surface antigens-new tool for genetic analysis. Cell, 14, 9-20 (1978).
4. 2 microglobulin gene result in lack of HLA class I molecules on melanoma cells of two patients immunized with MAGE peptides. Tissue Antigens, 52, 520-529 (1998).
5. 2 -Microglobulin gene mutations: a study of established colorectal cell lines and fresh tumors. Proc. nat. Acad. Sci. (Wash.), 91, 4751-4755 (1994).
6. BLASCHITZ, A., LENFANT, F., MALLET, V., HARTMANN, M., BENSUSSAN, A., GERAGHTY, D.E., LE BOUTEILLER, P. and DOHR, G., Endothelial cells in chorionic fetal vessels of first trimester placenta express HLA G. Europ. J. Immunol., 27, 3380-3388 (1997).
7. BURRONE, O.R., KEFFORD, R.F., GILMORE, D. and MILSTEIN, C., Stimulation of HLA ABC by IFN. The derivation of Molt 4 variant and the differential expression of HLA ABC subset. EMBO J., 4, 2855 (1985).
8. CABRERA, T., COLLADO, A., FERNANDEZ, M.A., FERRON, A., SANCHO, J., RUIZ CABELLO, F. and GARRIDO, F., High frequency of altered HLA class I phenotypes in invasive colorectal carcinomas. Tissue Antigens, 52, 114-123 (1998).
9. CABRERA, T., FERNÁNDEZ, M.A., SIERRA, A., GARRIDO, A., HERRUZO, A., ESCOBEDO, A., FABRA, A. and GARRIDO, F., High frequency of altered HLA class I phenotypes in invasive breast carcinomas. Hum. Immunol., 50, 127-134 (1996).
10. FARRELL, H.E., VALLY, H., LYNCH, D.M., FLEMING, P., SHELLAM, G.R., SCALZO, A.A. and DAVIS-POYNTER, N.J., Inhibition of natural killer cells by a cytomegalovirus MHC class I homologue in vivo. Nature (Lond.), 386, 510-514 (1997).
11. FRUMENTO, G., FRANCHELLO, S., GERAGTHY, D. and FERRARA, G.B., Analysis of HLA G expression in tumor cell lines. First International Conference on HLA G, July 6-7, Paris, France (1998).
12. GARRIDO, F., CABRERA, T., CONCHA, A., GLEW, S.S., RUIZ-CABELLO, F. and STERN, P., Natural history of HLA antigens during tumor development. Immunol. Today, 14, 491-499 (1993).
13. GARRIDO, F., CABRERA, T., LOPEZ-NEVOT, M.A. and RUIZ-CABELLO, F., HLA class I antigens in human tumors. Adv. Cancer Res., 67, 155-195 (1995).
14. GARRIDO, F. and RUIZ-CABELLO, F., MHC expression on human-tumors. Its relevance for local tumor growth and metastasis. Semin. Cancer Biol., 2, 1-2 (1991).
15. GARRIDO, F., RUIZ-CABELLO, F., CABRERA, T., PÉREZ-VILLAR, J.J., LÓPEZ-BOTET, M., DUGGAN-KEEN, M. and STERN, P.L., Implications for immunosurveillance of alterd HLA class I phenotypes in human tumors. Immunol. Today., 18, 89-95 (1997).
16. KAKLAMANIS, L. and HILL, A., MHC loss in colorectal tumors: evidence for immunoselection? Cancer Surveys, 13, 155-171 (1992).
17. KING, A., BOOCOCK, C., SHARKEY, A.M., GARDNER, L., BERETTA, A., SICCARDI, A.G. and LOKE, Y.W., Evidence for the expression of HLA-C class I mRNA and protein by human first trimester trophoblast. J. Immunol., 156, 2068-2076 (1996).
18. KIRKIN, A.F., PETERSEN, T.R., OLSEN, A.C., THOR STRATEN, P. and ZEUTHEN, J., Generation of human-melanoma-specific T lymphocyte clones defining novel cytolytic targets with panels of newly established melanoma cell lines. Cancer Imunol. Imunother., 41, 71-81 (1995).
19. KIRSZENBAUM, M., PHILIPPE, M., GLUCKMAN, E., DAUSSET, J. and CAROSELLA, E., An alternativaly spliced form of HLA G mRNA in human trophoblasts and evidence for the presence of HLA G transcript in adult lymphocytes., Proc. nat. Acad. Sci. (Wash.), 91, 4209-4213 (1994).
20. LE BOUTEILLER, P., HLA G: the track of immunological functions. Europ. J. Immunogenet., 24, 397-408 (1997).
21. LEONG, C.C., CHAPMAN, T.L., BJORKMAN, P.J., FORMANKOVA, D., PHILLIPS, J.H. and LANIER, L.L., Modulation of natural killer cell cytotoxicity in human cytomegalovirus infection: the role of endogenous class I major histocompatibility complex and a viral class I homolog. J. exp. Med., 187, 1681-1687 (1998).
22. LOKE, Y.W., KING, A., BURROWS, T., GARDNER, L., BOWEN, M., HIBY, S., HOWLETT, S., HOLMES, N. and JACOBS, D., Evaluation of trophoblast HLA G antigen with a specific monoclonal antibody. Tissue Antigens, 50, 135-146 (1997).
23. LOPEZ-NEVOT, M.A., CABRERA, T., DE LA HIGUERA, B., RUIZ-CABELLO, F. and GARRIDO, F., Production and characterization of monoclonal antibodies against leukemic cells. Inmunología, 5, 51-59 (1986).
24. 1 domain of HLA-A molecules. Inmunogenetics, 30, 50-53 (1989).
25. MORETTA, A., BIASONI, R., BOTTINO, C., PENDE, D., VITALE, M., POGGI, A., MINGARI, M.C. and MORETTA, L., Major histocompatibility complex class 1-specific receptors on human natural killer and T lymphocytes. Immunol. Rev., 155, 105-117 (1997).
26. ONNO, M., PANGAULT, C., CAULET-MAUGENDRE, S., GUILLOUX, V. and FAUCHET, R., Expression of HLA G antigens in activated tumor macrophages. First International Conference on HLA-G, July 6-7, Paris, France (1995).
27. PAUL, P., ROUAS-FREIS, N., KHALIL-DAHER, I., MOREAU, P., RITEAU, B., LE GAL, F.A., AVRIL, M.F., DAUSSET, J., GUILLET, J.G. and CAROSELLA, E., HLA G expression in melanomas: a way for tumor cells to escape from immunosurveillance. Proc. nat. Acad. Sci. (Wash.), 95, 4510-4515 (1998).
28. REAL, L.M., JIMENEZ, P., CANTON, J., KIRKIN, A., GARCIA, A., ABRIL, E., ZEUTHEN, J., RUIZ-CABELLO, F. and GARRIDO, F., In vivo and in vitro generation of a new altered HLA phenotype in melanoma-tumor-cell variants expressing a single HLA-class-I allele. Int. J. Cancer, 75, 317-323 (1998).
29. REYBURN, H.T., MANDELBOIM, O., VALES-GOMEZ, M., DAVID, D.M., PAZMANY, L. and STROMINGER, J.L., The class I MHC homologue of human cytomegalovirus inhibits attack by natural killer cells. Nature (Lond.), 386, 514-517 (1997).
30. 2 microglobulin mRNA in human Daudi cells has a mutated initiation codon but is still inducible by interferon. EMBO J., 2, 239-243 (1983).
31. 1 domain of HLA G1 and HLA G2 inhibits cytotoxicity induced by natural killer cells: is HLA G the public ligand for natural killer cell inhibitory receptors? Proc. nat. Acad. Sci. (Wash.), 91, 5249-5254 (1997).
32. SPEAR, B.T., KORNBLUTH, J., STROMINGER, J.L. and WILSON, D.B., Evidence for a shared HLA-A intralocus determinant defined by monoclonal antibody 131. J. exp. Med., 162, 1802-1810 (1985).
33. TORRES, M.J., RUIZ-CABELLO, F., SKOUDY, A., BERROZPE, G., JIMENEZ, P., CABRERA, T., REAL, F.X. and GARRIDO, F., Loss of an HLA haplotype in pancreas cancer tissue and its corresponding tumor derived cell line. Tissue Antigens, 47, 372-381 (1996).